US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

53.13

+0.08760.17%

Post-market: 53.12-0.0076-0.01%16:15 EDT

Volume:7K

Turnover:368.27K

Market Cap:179.04M

PE:- -

High:53.53

Open:53.04

Low:53.04

Close:53.04

52wk High:56.45

52wk Low:39.08

Shares:3.37M

Float Shares:3.37M

Volume Ratio:0.23

T/O Rate:0.21%

Dividend:0.00

Dividend Rate:0.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Corcept Names Roberto Vieira as President, Oncology in Initial Beneficial Ownership Filing

Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34

Krystal Biotech to Speak at Cantor Global Healthcare Conference Fireside Chat

Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan

Molina Healthcare Updates Financial Calendar with Third-Quarter Earnings Release, Conference Call

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Affordable Housing Stocks Investors Are Watching As Social Spending Moves Center Stage

Simply Wall St.

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million

Brightspring Health Services Inc Stock (BTSG) Closed Up by 7.20% on Aug 26: Key Drivers Unveiled

Roche receives FDA approval for companion diagnostic tests for Ziihera

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study

The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1

THOMSON REUTERS

Krystal Biotech (KRYS) Rallies On Pipeline Hopes But Is The Valuation Already Priced In

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PSCH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":53.1276,"timestamp":1789588800000,"preClose":53.04,"halted":0,"volume":6911,"hourTrading":{"tag":"盘后","latestPrice":53.12,"preClose":53.1276,"latestTime":"16:15 EDT","volume":12,"amount":637.5456,"timestamp":1789589700249,"change":-0.0076,"changeRate":-0.000143,"amplitude":0},"delay":0,"changeRate":0.0016515837104072756,"floatShares":3370000,"shares":3370000,"eps":0,"marketStatus":"Not Yet Opened","change":0.0876,"latestTime":"09-16 16:00:00 EDT","open":53.04,"high":53.53,"low":53.04,"amount":368269,"amplitude":0.009238,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":53.04,"sharesOutstanding":3220000,"nav":53.02234,"aum":183987519.8,"dividendRate":0.000056,"bidAskSpread":0.001542,"postHourTrading":{"tag":"盘后","latestPrice":53.12,"preClose":53.1276,"latestTime":"16:15 EDT","volume":12,"amount":637.5456,"timestamp":1789589700249,"change":-0.0076,"changeRate":-0.000143,"amplitude":0},"volumeRatio":0.229849,"impliedVol":0.1092,"impliedVolPercentile":0.7171},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3370000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.229849,"shares":3370000,"dividePrice":0.003,"high":53.53,"amplitude":0.009238,"preClose":53.04,"low":53.04,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":53.1276,"eps":0,"divideRate":0.000056,"volume":6911,"delay":0,"ttmEps":0,"open":53.04,"prevYearClose":44.0553,"prevWeekClose":52.9516,"prevMonthClose":54.61,"prevQuarterClose":52.3666,"fiveDayClose":53.7131,"twentyDayClose":55.27,"sixtyDayClose":48.6301},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664800115","title":"Corcept Names Roberto Vieira as President, Oncology in Initial Beneficial Ownership Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800115","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800115?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:40","pubTimestamp":1788482411,"startTime":"0","endTime":"0","summary":"Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filingCorcept Therapeutics President, Oncology Roberto Wandenkolk Vieira disclosed 4,068 common shares in an initial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL3ZgV8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","BK4007","LU1559883803.SGD","LU0566484027.USD","FBT","CORT","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802637","title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802637","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802637?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:33","pubTimestamp":1788474793,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin disposes of 2,034 common shares worth $97,651.34Alkermes EVP and chief legal officer David Joseph Gaffin sold 2,034 ordinary shares on Sep. 3, 2026 at USD 48.01.D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL5DSLJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","MEDX","IBRN","PSIL","FBT","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871013","title":"Krystal Biotech to Speak at Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871013","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871013?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:07","pubTimestamp":1788437263,"startTime":"0","endTime":"0","summary":"Krystal Biotech to speak at Cantor Global Healthcare Conference fireside chatKrystal Biotech will participate in the 2026 Cantor Global Healthcare Conference on Sept. 10, 2026, in New York.Management ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL65Fmjd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","SG9999014021.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00B64PRP62.GBP","KRYS","BK4112","BK4585","LU2210149790.SGD","BCDF","IE00BGHQF748.EUR","NDAQ","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","LU2095319765.USD","IE00BQXX3D17.EUR","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014039.USD","LU0314104364.USD","IE00BQXX3F31.USD","LU2210150020.SGD","HELX","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664876603","title":"Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664876603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664876603?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:11","pubTimestamp":1788433869,"startTime":"0","endTime":"0","summary":"Some stocks face a vey different environment depending on how America votesThe battle in Texas between Democratic nominee James Talarico, left, and Republican candidate Ken Paxton could swing the U.S.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MST","LU1992135399.USD","IE00BGHQF524.EUR","BK4168","LU2505996509.AUD","LU2360107168.USD","IE0034235303.USD","LU0256863811.USD","LU0943347566.SGD","LU0251131958.USD","LU1323610961.USD","IE00BD4GTV84.USD","LU2092937221.SGD","IE00BZ9MQY76.HKD","LU2168564065.EUR","LU1037948897.HKD","LU2065171402.SGD","LU1548497426.USD","APED","LU2357627491.SGD","3SMI.UK","LU2637965513.SGD","IE0009356076.USD","LU2362541513.USD","LU1674673691.USD","BK4550","IMST","ESLG","COIO","LU1791710400.SGD","LU0368265418.SGD","LU2272731865.HKD","LU2592432038.USD","LU2506952097.USD","LU0203201768.USD","IE00BJLML261.HKD","LU1951198990.SGD","HOOG","LU0149725797.USD","SG9999015945.SGD","BITQ","BK4605","LU0310800379.SGD","LU0882574139.USD","LU2106854487.HKD","LU1674673428.USD","SHOC","WMB","LU0942090050.USD","IE0004086264.USD","LU0511384066.AUD","BK4207","IE00BVYPNP33.GBP","LU0081259029.USD","LU1861558580.USD","LU2065170008.USD","MDST","LU1116320737.USD","LU0965509101.SGD","LU1267930573.SGD","LU0109391861.USD","LU2931357623.SGD","FINX","LU2505996681.GBP","LU2954938101.SGD","LU0057025933.USD","MSTZ","LU0444971666.USD","LU0630314457.HKD","BK4535","LU2552382058.USD","LU2357305700.SGD","LU1815333072.USD","TTEQ","LU0109392836.USD","LU1720051017.SGD","LU0640476718.USD","LU0320765489.SGD","LU0053666078.USD","LU0157215616.USD","XLP","IE00BD6J9T35.USD","IE00B5949003.HKD","LU1935043023.USD","WMTI","LU1894683348.USD","LU1868836591.USD","LU0211328371.USD","EINC","CNCG","LU0795875086.SGD","LU1815336760.USD","LU0949170426.SGD","BK4023","LU1691799644.USD","LU2041044095.USD","LU0823417653.USD","LU2506951958.HKD","HOII","LU0130102774.USD","IAI","USAI","BK4547","BK4534","LU2462591350.SGD","LMTL","FENY","LU1935042991.SGD","MS","LU0133085943.USD","KTOS","LU2746668974.SGD","BK4144","LU2456880835.USD","SPTE","CHPX","LU1363072403.SGD","LU0256863902.USD","LU0354030511.USD","EIPI","LU0251132253.USD","LU1116320901.HKD","LU2487616109.SGD","LU1032466523.USD","DRNZ","HOYY","SNOW","LU1732799900.SGD","BK4109","LU2250418816.HKD","LU0912757837.SGD","KBWB","LU0683600562.USD","LU1923622291.USD","IE00B7KXQ091.USD","BK4520","CNC","LU0130518102.USD","LU0211327993.USD","LU1861220033.SGD","LU0348723411.USD","LU1242518931.SGD","WEEI","CLOU","IVEP","DIPR","BK4551","LIMI","EVRDD","IE00B19Z4B17.USD","LU2265009873.SGD","LU2430703251.USD","XLF","LU2125154935.USD","BK4588","JPO","LU2764263203.CNY","IE00B42XCP33.USD","LU2860962120.EUR","SAVGOmain","LU0072461881.USD","FDIG","09311","CONL","LU0265550359.USD","LU0320765646.SGD","LU1868836757.USD","SG9999002224.SGD","LU1623119135.USD","IE00BQXX3D17.EUR","SG9999015978.USD","DAT","LU0215105999.USD","LU1430594728.SGD","MPG","LU0187121727.USD","LU0477156953.USD","LU1878469433.USD","AVAV","LIT","LU1989763427.SGD","HODU","LU1301847155.USD","LU0823411888.USD","LU2756315318.SGD","FAI","LU1064131342.USD","LU1169590202.USD","FTEC","SG9999014005.SGD","LU0823414551.USD","LU2083900584.USD","BK4505","HAKY","IE00BDGV0183.EUR","LU0868494617.USD","LU0689626769.HKD","LU1861559042.SGD","LU1035773651.USD","CIBR","LU1496350502.SGD","LU1929549753.HKD","LU0820562030.AUD","LU1868837300.USD","LU2249611893.SGD","LU0048573561.USD","ILIT","GD","LU0070302665.USD","LU0354030438.USD","LU2264538146.SGD","CHAT","LU1791807156.HKD","LU0965509010.AUD","LU2360106780.USD","MSTW","LU2237443895.HKD","USXF","COYY","IE00BQXX3F31.USD","MSTU","LU2286300806.USD","LU2089985449.USD","HK0000819398.USD","LU1162221912.USD","LU1291159041.SGD","LU1074936037.SGD","BK4603","ALB","IE00B7SZLL34.SGD","IE00B7SZL793.SGD","IE00BMPRXN33.USD","LU1267930490.SGD","LU1144417596.USD","HWAY","LU1201861165.SGD","LU1791710582.SGD","LU1084165304.USD","BK4515","LU0124676726.USD","ROKT","LU0225283273.USD","MLPI","CONY","LU0648000940.SGD","LU0496365809.HKD","LU2168564149.EUR","MP","LU2023251221.USD","LU2471134952.CNY","KMI","LU2506952170.USD","IE000M9KFDE8.USD","LU0128525929.USD","LU2298321311.HKD","OWNB","IE00BYXW3230.USD","LU1169589451.USD","LU2108987350.USD","LU0965509283.SGD","SG9999004303.SGD","LU0456854461.SGD","AVGG","LU1814569148.SGD","LU1974910355.USD","LU1629891620.HKD","WDGF","LU0949170772.SGD","BK4532","LU2210149790.SGD","AVGC","IE00BJTD4V19.USD","LU2111349929.HKD","BK4097","MSST","LU1244550494.USD","LMTS","LU1988902786.USD","LU2271345857.HKD","IE00BBT3K403.USD","BK4528","IE00BMCWC346.EUR","LU0162691827.USD","LU1621768115.EUR","LU0079474960.USD","LU0661504455.SGD","LU0070217475.USD","LULG","USD","LU2384288077.EUR","LU0390134368.USD","NATO","MLPX","LU0300736492.USD","LU0553294199.USD","BK4512","VGT","BK4564","LU1935042215.USD","BK4503","LU0742534661.SGD","LU0323239441.USD","LU0061474960.USD","LU1718418525.SGD","SG9999011175.SGD","IE00BWXC8680.SGD","LU0122376428.USD","LU1621767737.EUR","SOXQ","ROST","LU0265550946.USD","LU1201861249.SGD","LU1803068623.USD","KTUP","LU2237957902.USD","SNOU","LU2417539215.USD","IE00BKDWB100.SGD","LU0859254822.USD","LU0545039389.USD","IYF","LU1934455194.USD","LU0823417737.USD","LU0208291251.USD","FNCL","IE00B3PB1722.GBP","ROBN","LU1699723380.USD","LU0979878070.USD","LU2506951875.HKD","IE00B19Z3581.USD","BK4575","LU1119994496.HKD","ICOI","LU2065169927.USD","LU0345768740.USD","LU1551013342.USD","WNTR","LU2552382132.HKD","LU1868836914.USD","LU0823434583.USD","LU0048584097.USD","LU1642822529.SGD","LU2361044949.HKD","LU0310799852.SGD","07799","BK4114","DFEN","SG9999015986.USD","LU2361045086.USD","LU2133065610.SGD","LU1621767810.EUR","SG9999002521.SGD","IE00B1BXHZ80.USD","LU0266512473.USD","HOOX","LU2244417387.USD","IYG","LU2357125470.USD","LU0642271901.SGD","EVR","LU0289739343.SGD","LU1066053197.SGD","LU0082616367.USD","MTYY","BK4543","NVIR","LU0648001328.SGD","LU1861219969.SGD","LU1935042488.USD","IE00B1XK9C88.USD","LU0203202063.USD","LU0505663152.USD","IE00BDCRKT87.USD","SGXZ23171101.USD","TEK","LU2095319765.USD","LU2237438978.USD","LU2360032135.SGD","09799","ALBG","LU0417517546.SGD","LU2360107671.USD","LU2746668461.USD","SGXZ51526630.SGD","LU2272731782.SGD","ARTY","LU0345769128.USD","LU0056508442.USD","LU2462157665.USD","LU0353189763.USD","LU2720916845.USD","AIFD","IE00BLSP4452.SGD","LU1989764664.SGD","PPA","LU0472753341.HKD","LU1066051225.USD","HOOD","LU0323240290.USD","LU2272731600.USD","LU2420271590.USD","IE00B19Z9P08.USD","UXI","LU0787776722.HKD","LU2236285917.USD","SGXZ81514606.USD","LU0080751232.USD","SG9999014021.USD","BK4600","BK4598","LU2054465674.USD","LU1670627923.USD","LU2433249047.HKD","TRUO","IE00BK4W5M84.HKD","LU0345770993.USD","LU1066051811.HKD","BK4149","LULU","07311","IE0001KFT4U8.USD","3LMI.UK","REXC","LU0211331839.USD","LU0345768153.USD","LU1923622614.USD","IE00BK4W5L77.USD","LU2322448791.USD","LU0143551892.USD","BK4185","RTH","LU2168564222.USD","TTXU","LU1621768206.USD","LU2355687059.USD","LU1261432733.SGD","LU0174119429.USD","IE00BFSS7M15.SGD","IE00BN29S564.USD","LU2463526074.USD","SG9999015952.SGD","BK4213","BESF","BK4516","IE00B3CCJ963.GBP","IE00B775SV38.USD","GASZ","LU2290526834.HKD","LU0308772762.SGD","TDIV","LU0708995401.HKD","ZS","AVL","BK4127","LU0820561909.HKD","LU0006306889.USD","LU2089284900.SGD","LITP","LU2237443465.HKD","LU1989772840.SGD","TPZ","MSTK","PSCH","MADE","LU2097829019.USD","CRPT","BK4141","SG9999001440.SGD","IE0004091025.USD","LU0154236417.USD","LU2247934214.USD","LU1934455277.USD","MSTY","BKCH","ENFR","LU0786609619.USD","LU1244550577.SGD","IEO","IE00BMG7P926.USD","WISE","LU1670756490.USD","LU1670710588.SGD","COIA","LU0738911758.USD","SOXX","LU2242650005.HKD","LU1868837136.USD","IE00B19Z3B42.SGD","AVGW","LU0203347892.USD","PXE","LU2213496289.HKD","IE00BMG7P694.USD","IE00BD4GTT62.SGD","LU0211326755.USD","IE0034235188.USD","LU1989763690.USD","LU2028103732.USD","SG9999003800.SGD","TRUI","LU2089283258.USD","LU2324357040.USD","LU2065171311.SGD","IE00BDRTCR15.USD","IE00BMPRXR70.SGD","LU0300736062.USD","BK4554","LU0724617625.USD","IE00BMG7P819.SGD","LU2430703095.HKD","BK4612","BK4566","LU0106831901.USD","IE00BJTD4N35.SGD","LU1923623000.USD","LU1366333091.USD","MSTX","LU1670628061.USD","LMT","IE00BLSP4239.USD","IE0004445239.USD","LU1670710661.SGD","BK4155","IE00B66KJ199.SGD","LU0957808578.USD","LU1989771016.USD","COIW","LU0267386448.USD","LU1934455863.HKD","BK4187","CAT","AVS","LU1127390331.HKD","MOH","LU2360108059.USD","CGGO","TNGY","LU1992135472.HKD","VFH","LU0444973449.USD","MSTR","LU2362541273.HKD","LU0345781412.USD","LU1861217088.USD","LU2756315664.SGD","LU0788109394.HKD","LU0784385170.HKD","LU1153585028.USD","JGRO","HK0000914660.USD","LU1551013425.SGD","LU0274383776.USD","LU2087625088.SGD","LU2471134523.USD","POWR","LU1242518857.USD","LU0106261372.USD","LU2458330169.SGD","IE00BMG7P587.USD","IE0005OL40V9.USD","USNG","LU0889565833.HKD","BK4552","LU0203345920.USD","LU0069063385.USD","LU0784385840.USD","TRUN","ITA","LU1400636657.SGD","LU2381873111.SGD","FOWF","IXG","LU0965508806.USD","LU0097036916.USD","LU1894683264.USD","MISL","LU0868494708.USD","NULC","TPYP","XDAT","TFNS","BK4595","LU2242649171.HKD","LU1232071149.USD","BK4094","IYE","LU0820561818.USD","LU1035775433.USD","IE00BN8TJ469.HKD","LU1720051108.HKD","LU0029864427.USD","LU0266512127.USD","IXN","LU0210533765.USD","LU0158827781.USD","LU0823414478.USD","CATG","RSPG","IE000WXP2NQ0.USD","LU0072462426.USD","LU0719512351.SGD","LU0198837287.USD","LU0316494557.USD","LU2764262908.HKD","LU2023250843.SGD","LU1267930730.SGD","07399","DG","LU2461242641.AUD","BK4559","IE00BD4GTW91.USD","LU1400636491.USD","IE00BMPRXQ63.HKD","LU1066051498.USD","LU1803068979.SGD","LU1861214812.USD","REMX","LU2210150020.SGD","TEXU","LU0345780950.USD","LU0689472784.USD","LU1951200564.SGD","LU2125909247.SGD","09711","LMI3.UK","LU2403377893.USD","LU1496350171.SGD","LU0061474705.USD","HK0000914686.HKD","LU0098860793.USD","LU2048586759.USD","LU0976567544.SGD","CONX","LU2063271972.USD","LU0672654240.SGD","BK4604","BK4607","LU1244550221.USD","LU1861215975.USD","BK4504","BK4613","IE00B19Z9Z06.USD","LU0466842654.USD","LU1852331112.SGD","LU1861220207.SGD","SG9999002232.USD","BK4548","AVGX","IE00BSNM7G36.USD","LU0795875169.SGD","UYG","LU1280957306.USD","LU2430703178.SGD","LU1914381329.SGD","FIAT","LU0314104364.USD","BK4116","IE00BMG7P702.HKD","LU0061475181.USD","LU2552382215.SGD","SGXZ99366536.SGD","LU0210528500.USD","LU0289961442.SGD","IE0004445015.USD","LU0784383803.USD","LU0006061336.USD","HOOZ","LU2211814178.USD","LU2347655073.USD","IE00BVYPNQ40.USD","TRUF","LU1400636574.HKD","LU1935043536.SGD","LU0476273544.USD","LU1037948541.HKD","IE000SL1IH01.SGD","HOOY","LU0353189680.USD","BLCK","IE00BZ1G4Q59.USD","VDE","MPL","LU0980610538.SGD","LU2237443978.SGD","SNOY","IDEF","LU2023250504.SGD","AVGO","LU1979441026.SGD","MSDD","DIG","LU0477156797.USD","RTX","LU2211815571.USD","LU0158827948.USD","LU2168564495.EUR","LU2360107325.USD","LU1815336091.USD","LU0784384876.USD","IE0034235295.USD","MSII","HOOI","BK4585","LU2602419157.SGD","RSHO","BK4539","HK0000532082.HKD","LU2237443549.SGD","BK4596","LU0345770308.USD","BK4597","LU0345769631.USD","LU0823434740.USD","LU0234570918.USD","LU2463028550.USD","LU0320765059.SGD","LU0964807845.USD","MSOO","LU1316542783.SGD","LU2237443622.USD","GXPE","IE00BGHQDM52.EUR","LU0127658192.USD","SMST","BK4560","MSTC","COII","IE00BJJMRY28.SGD","LU1145028129.USD","THMR","LU1712237335.SGD","LU2473716301.USD","BPAY","IETC","LU1732800096.USD","LU2279689827.SGD","LU0985320562.USD","LU0096362180.USD","XLE","IE00BYV24P56.USD","IDRV","GB00BDT5M118.USD","LU0861579265.USD","LU1585245621.USD","CGBL","LU2125909593.SGD","LU2361044865.SGD","AVXX","IE00BHPRN162.USD","WMT","BK4154","LU2362540622.SGD","COIN","IE0002270589.USD","LU1069347547.HKD","BK4545","LU0175139822.USD","LU0211326839.USD","LU0323591593.USD","CGDG","FCG","JPMO","SMI3.UK","LU1003077747.HKD","LU2506951792.HKD","LU2322448957.HKD","07711","EMLP","IE00BVYPNV92.GBP","COIX","LNGX","CONI","UMI","IE00B3S45H60.SGD","IE00BKPKM429.USD","09399","TRFK","LU0726765562.USD","LU2237443382.USD","IE00B4JS1V06.HKD","LU0011850046.USD","LU1804176565.USD","SG9999014013.SGD","LU0289960550.SGD","LU1645745479.HKD","LU2125909759.SGD","LU1989764748.USD","IE0031619046.USD","LU0238689110.USD","LU2462591277.SGD","IE00BGHQF631.EUR","FSTA","HOOW","LU0950375773.USD","DOCU","IE00BVYPNW00.USD","LU1670711040.USD","LU2458330243.SGD","LU1778281490.HKD","LU0130103400.USD","LU0266013472.USD","IE00B2Q91V27.USD","BK4581","LU1069344957.HKD","LU2125909916.SGD","LU2750360997.AUD","MSTP","MSTY.UK","LU0971096721.USD","SHLD","JPM","LU0757428866.USD","IE00BQXX3C00.GBP","IE00BFSS8Q28.SGD","LU0557290698.USD","IE00BJJMRX11.SGD","LU2750360641.GBP","SETM","SG9999001424.SGD","LU2471134879.HKD","LU0096364046.USD","LU2168563687.JPY","XLK","AVGU","LU1917777945.USD","SMHX","LU2471134796.USD","LU2237957811.SGD","LU2125154778.USD","LU1668664300.SGD","DAPP","IBLC","LU2294711713.HKD","LU1989772923.USD","BZZ","LU0251142724.SGD","LU0963586101.USD","LU0170899867.USD","LU0788109477.HKD","LU2023250330.USD","LU2347655156.SGD","LU0276348264.USD","LU0957791311.USD","LU0234572021.USD","RTXG","SG9999000418.SGD","LU1202635105.USD","EXI","THC","COIG","BAI","FTXO","LU0130517989.USD","LU0210536198.USD","LU0528227936.USD","LU2543165471.USD","HOOC","LU1670711123.USD","LU0094547139.USD","IE000HOSIQF4.USD","BK4112","IE00BKVL7J92.USD","GSX","IE00B894F039.SGD","UGE","LU0708994859.HKD","BK4202","EQT","MRCY","LU2764263039.SGD","GS","SG9999014039.USD","IE00BFXG1179.USD","BK4533","LU2999663052.SGD","LU2896262040.SGD","IE00B775H168.HKD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814141","title":"Molina Healthcare Updates Financial Calendar with Third-Quarter Earnings Release, Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814141","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814141?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:01","pubTimestamp":1788354096,"startTime":"0","endTime":"0","summary":"Molina Healthcare updates financial calendar with third-quarter earnings release, conference callMolina Healthcare schedules third-quarter earnings release for Oct. 21, 2026, covering the period ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL777nyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","SG9999014021.USD","BK4154","PSCH","MOH","BK4588","BK4532","BK4585","SG9999014005.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864142","title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864142","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864142?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:09","pubTimestamp":1788304180,"startTime":"0","endTime":"0","summary":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson disposes of 9,000 shares for $422,874Craig C. Hopkinson, EVP R&D, Chief Medical Officer, sold 9,000 ordinary shares on Sep. 1 at USD 46.99.He","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLgbNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","PSIL","FBT","BK4139","IBRN","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881865","title":"Affordable Housing Stocks Investors Are Watching As Social Spending Moves Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881865","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881865?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:23","pubTimestamp":1788218588,"startTime":"0","endTime":"0","summary":"As US politics tilts further left and Democratic Socialists of America backed candidates push ideas like housing for all, affordable housing and community services are moving from the sidelines to center stage for investors. Policy risk is rising for some sectors, yet fresh funding and regulatory shifts could reshape others. This article walks through 3 stocks exposed to these social infrastructure themes and how this backdrop might affect their long term story.\nThe three stocks below are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3112400-choice1-main-header/1585186606618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112400-choice1-main-header/1585186606618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/nyse-bfam/bright-horizons-family-solutions/news/affordable-housing-stocks-investors-are-watching-as-social-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nyse-bfam/bright-horizons-family-solutions/news/affordable-housing-stocks-investors-are-watching-as-social-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BKD","GLS.SI","LU2190626999.HKD","BTSG","ISBC","LU2468319806.SGD","JJJ.SI","LU0842063009.USD","SRT.SI","LU1499592464.USD","BK4204","CFA.SI","LU0054578231.USD","LU2089984988.USD","SRU.SI","BK4185","CLR.SI","PSCH","BK4211","BK4196","BFAM","LU2324357040.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","PINK","LABU","MEDI","SYNB","IYH","NVIB","MRNX","TBXU","BBP","BK4139","IBB","IDNA","FRTY","BK4007","TAK","MRNY","LFSC","GNMX","PSCH","PTGX","RSPH","GDOC","IEIH","XLVX","BK4588","TECB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011648","title":"Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011648","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011648?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:06","pubTimestamp":1787969183,"startTime":"0","endTime":"0","summary":"New insider activity at Corcept Therapeutics ( ($CORT) ) has taken place on August 28, 2026. Director Park Kimberly has recently cashed out a signi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/corcept-therapeutics-insider-makes-major-multimillion-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/corcept-therapeutics-insider-makes-major-multimillion-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","LU1559883803.SGD","BK4007","FBT","CORT","BK4532","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BK4588","IYH","NVIB","MRNX","BMED","SYNB","MEDI","PSCH","RSPH","TECB","IDNA","LABU","GDOC","BBP","XLVX","LFSC","IBB","TBXU","MRNY","IEIH","BK4585","GNMX","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","LFSC","PINK","IDNA","BK4007","GDOC","RSPH","XLVX","MRNY","GNMX","TBXU","BMED","PSCH","MRNX","IBB","BK4588","FRTY","TECB","MEDI","IEIH","TAK","IYH","BK4585","LABU","SYNB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033320","title":"Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033320","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033320?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:31","pubTimestamp":1787862696,"startTime":"0","endTime":"0","summary":"Corcept Endocrinology President Sean Maduck disposes of 30,955 Corcept shares worth $3.88 millionCorcept Therapeutics President, Corcept Endocrinology Sean Maduck exercised stock options for 30,955 co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLbYdy60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0566484027.USD","CORT","PSCH","LU1559883803.SGD","BK4007","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574411","title":"Brightspring Health Services Inc Stock (BTSG) Closed Up by 7.20% on Aug 26: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574411","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662574411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:15","pubTimestamp":1787775315,"startTime":"0","endTime":"0","summary":"• BrightSpring reported strong second-quarter revenue and raised its full-year guidance.\n• Wall Street analysts maintained buy ratings with an average price target of $78.97.\n• Annual revenue reached $12.91 billion with a net profit of $190.67 million.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262133901-market-movers-btsg-20260826","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BTSG","LU2089984988.USD","PSCH","LU2468319806.SGD","BK4196","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","PINK","IEIH","LABU","LFSC","BK4585","CANC","GNMX","IYH","NVIB","BMED","TBXU","PSCH","IBB","XLVX","GDOC","BK4588","RHHBY","HRTS","TECB","03165","MRNX","SYNB","BBP","IDNA","FRTY","BK4007","MRNY","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","MEDI","MRNY","IEIH","CANC","LABU","GNMX","TECB","IYH","GDOC","PSCH","IE0009354923.USD","RVMD","IE00BJJMRZ35.SGD","PINK","SYNB","BK4139","LU0320765992.SGD","NVIB","LFSC","PTH","LU0889565916.HKD","BMED","TBXU","BBH","IDNA","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4585","BBP","MRNX","XLVX","LU0109394709.USD","RSPH","BK4588","FRTY","IE0002141913.USD","IBB","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IDNA","LU0889565916.HKD","BBH","BBP","RSPH","IE00B2B36J28.USD","IE0009354923.USD","XLVX","IEIH","BK4585","PSCH","IYH","IE00BJT1NW94.SGD","BMED","IE0002141913.USD","LU0109394709.USD","PTH","LABU","RVMD","IBB","LU0320765992.SGD","TBXU","LFSC","MRNY","GNMX","SYNB","BK4139","GDOC","IE0009355771.USD","CANC","TECB","NVIB","PINK","MRNX","IE00BJJMRZ35.SGD","MEDI","IE00B4R5TH58.HKD","FRTY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530687","title":"BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530687","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530687?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669120,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the U.S. FDA has approved the supplemental Biologics License Application for TEVIMBRA in combination with ZIIH...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BBP","BK4588","XLVX","MEDI","LABU","LFSC","BK4585","BMED","GNMX","MRNX","IYH","PSCH","SYNB","NVIB","TBXU","PINK","IDNA","RSPH","TECB","BK4139","BK4526","IEIH","GDOC","IBB","ONC","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662620199","title":"Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662620199","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662620199?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:30","pubTimestamp":1787610625,"startTime":"0","endTime":"0","summary":"Alkermes’ alixorexton posts positive Phase 2 Vibrance-1 results in narcolepsy type 1 studyAlkermes reported publication of positive Phase 2 Vibrance-1 results for alixorexton in adults with narcolepsy type 1 in The Lancet Neurology.Results were previously announced, not newly presented, showing improved daytime wakefulness and sleepiness measures versus placebo.Study also indicated reduced cataplexy at one dose, with broader patient-reported benefits in daily functioning.Safety profile appeared generally well tolerated, with mostly mild-to-moderate adverse events and no serious treatment-emergent events reported.Positive Phase 2 readouts supported the launch of the global Phase 3 Brilliance program testing once-daily and split-dose regimens in narcolepsy types 1 and 2.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL56tjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","PSCH","FBT","IBRN","BK4139","MEDX","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662201993","title":"The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2662201993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662201993?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:30","pubTimestamp":1787610600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA7VQ936:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","PSIL","ALKS","FBT","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661652248","title":"Krystal Biotech (KRYS) Rallies On Pipeline Hopes But Is The Valuation Already Priced In","url":"https://stock-news.laohu8.com/highlight/detail?id=2661652248","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661652248?lang=en_us&edition=fundamental","pubTime":"2026-08-23 17:16","pubTimestamp":1787476617,"startTime":"0","endTime":"0","summary":"Krystal Biotech stock performance snapshot\nKrystal Biotech (KRYS) has attracted fresh attention after recent share price gains, with the stock closing at $346.58 on 19 August 2026. Investors are weighing these moves against its recent return profile and fundamentals.\nOver the past month the stock shows a 3.4% return, with about 15.7% in the past 3 months and 40.4% year to date. Its 1 year total return is 130.3%, while the 3 year figure is approximately 1.7 times and the 5 year total return is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-rallies-on-pipeline-hopes-but-is-the-va","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-krys-rallies-on-pipeline-hopes-but-is-the-va","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HELX","KRYS","XBI","BK4588","BK4139","PSCH","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}